Ticker,Title,Link
INKT,MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference,9/3/2024 1:30:00 PM
INKT,"Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (INKT), Silence Therapeutics (SLN) and Mersana Therapeutics (MRSN)",8/16/2024 6:30:30 AM
INKT,MiNK Therapeutics files to sell 4.64M shares of common stock  for holders,8/13/2024 8:45:34 PM
INKT,MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report,8/1/2024 1:30:00 PM
INKT,MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement,7/31/2024 1:30:00 PM
INKT,MiNK Therapeutics Announces Virtual Annual Shareholders Meeting,6/5/2024 1:30:00 PM
INKT,MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting,5/22/2024 1:30:00 PM
INKT,MiNK Therapeutics Poised for Growth with Strong Trial Enrollment and New Investments: A Buy Rating from Jack Allen,5/16/2024 8:16:52 AM
INKT,INKT Stock Earnings: MiNK Therapeutics Beats EPS for Q1 2024,5/14/2024 3:52:49 PM
INKT,MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer,5/13/2024 1:30:00 PM
INKT,MiNK to Provide Corporate Update and First Quarter 2024 Financial Report,4/30/2024 1:30:00 PM
INKT,MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR,4/8/2024 6:00:00 PM
INKT,Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session,4/5/2024 7:06:13 PM
INKT,Buy Rating for MiNK Therapeutics Amidst Promising AGENT-797 Progress and Strategic Financial Moves,3/25/2024 1:48:00 AM
INKT,INKT Stock Earnings: MiNK Therapeutics Misses EPS for Q4 2023,3/21/2024 3:53:36 PM
INKT,MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report,3/7/2024 1:30:00 PM
INKT,MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024,3/6/2024 2:30:00 PM
INKT,First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab,2/14/2024 2:00:00 PM
INKT,"Analysts’ Top Healthcare Picks: Ascendis Pharma (ASND), BridgeBio Pharma (BBIO)",2/9/2024 6:02:56 AM
INKT,"MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications",2/6/2024 2:00:00 PM
INKT,MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene,1/30/2024 2:00:00 PM
INKT,"ImmunoScape, MiNK Therapeutics Join To Develop Next-generation TCR Therapies ",12/20/2023 2:37:28 PM
INKT,Positive Outlook for MiNK Therapeutics Amid Strong 3Q23 Earnings and Promising aGenT-797 Therapy Data,11/9/2023 5:09:38 PM
INKT,MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023,11/3/2023 5:00:00 PM
INKT,MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update,10/30/2023 1:00:00 PM
INKT,MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023,9/27/2023 3:05:00 PM
INKT,MiNK Therapeutics to Participate in September Investor Conferences,8/24/2023 2:30:00 PM
INKT,Robert W. Baird Keeps Their Buy Rating on MiNK Therapeutics (INKT),8/11/2023 4:16:02 PM
INKT,MiNK Therapeutics (INKT) Gets a Buy from H.C. Wainwright,8/10/2023 3:15:08 PM
INKT,B.Riley Financial Sticks to Their Buy Rating for MiNK Therapeutics (INKT),5/19/2023 2:35:07 AM
INKT,H.C. Wainwright Sticks to Its Buy Rating for MiNK Therapeutics (INKT),5/18/2023 3:25:08 PM
INKT,Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying,5/15/2023 1:41:01 PM
INKT,The Latest Analyst Ratings for MiNK Therapeutics,5/12/2023 3:01:54 PM
INKT,"MiNK Therapeutics GAAP EPS of -$0.22 beats by $0.02, revenue of $22.9M",5/10/2023 9:41:46 PM
INKT,"Immuron, ANI Pharmaceuticals top healthcare gainers; Catalent, Aptorum among losers",5/8/2023 2:03:22 PM
INKT,"KEY, NNOX and CMA are among pre-market gainers",5/5/2023 12:33:01 PM
INKT,"Soligenix, ZimVie top healthcare gainers; Sensus, Zynex among losers",5/4/2023 2:00:25 PM
INKT,Robert W. Baird Keeps Their Buy Rating on MiNK Therapeutics (INKT),4/21/2023 12:05:45 PM
INKT,H.C. Wainwright Keeps Their Buy Rating on MiNK Therapeutics (INKT),4/19/2023 10:25:13 AM
INKT,"Premier cancer research event, AACR is starting this week; Here is what to expect",4/9/2023 4:00:00 PM
INKT,"Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), MiNK Therapeutics (INKT)",3/22/2023 10:20:28 AM
INKT,MiNK Therapeutics GAAP EPS of $0.23,3/21/2023 12:59:27 PM
INKT,Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,1/4/2023 7:17:01 PM
INKT,MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference,11/17/2022 3:00:00 PM
INKT,Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday,11/14/2022 8:35:17 AM
INKT,MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline,11/10/2022 3:05:00 PM
INKT,H.C. Wainwright Sticks to Its Buy Rating for MiNK Therapeutics (INKT),11/3/2022 3:35:07 PM
INKT,MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update,10/20/2022 3:00:00 PM
INKT,"MiNK Therapeutics to Host R&D Event November 10, 2022",10/5/2022 3:16:53 PM
INKT,MiNK Therapeutics to Participate at Upcoming Investor Conferences,8/31/2022 3:00:00 PM
INKT,"Curis, Allarity top healthcare gainers; Blue Water, Accelerate Diagnostics lead losers' pack",8/18/2022 2:01:23 PM
INKT,"Blue Water, Eargo top healthcare gainers; Blueprint, Artelo lead losers' pack",8/17/2022 2:00:14 PM
INKT,"Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session",8/16/2022 6:54:04 PM
INKT,"REV, MYMD and LDI among mid-day movers",8/15/2022 5:19:15 PM
INKT,MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results,8/9/2022 2:00:00 PM
INKT,MiNK Therapeutics to Participate at BTIG Biotechnology Conference,8/2/2022 2:30:00 PM
INKT,MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update,7/27/2022 2:30:00 PM
INKT,"Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday",6/27/2022 10:26:40 AM
INKT,"Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday",6/24/2022 11:35:01 AM
INKT,"ELMS, EMWP and EOSE among mid-day movers",6/16/2022 4:54:31 PM
INKT,70 Biggest Movers From Friday,5/31/2022 11:15:40 AM
INKT,MiNK Therapeutics Announces Virtual Annual Shareholders Meeting,5/25/2022 2:30:00 PM
INKT,MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report,5/10/2022 2:00:00 PM
INKT,MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update,4/27/2022 11:19:52 PM
INKT,68 Biggest Movers From Yesterday,4/19/2022 10:35:35 AM
INKT,"AIM, PTE and PHIO among mid-day movers",4/12/2022 4:48:09 PM
INKT,53 Biggest Movers From Yesterday,4/8/2022 10:49:38 AM
INKT,38 Stocks Moving In Thursday's Mid-Day Session,4/7/2022 7:14:13 PM
INKT,"JANX Advances Pipeline, INKT To File IND, Will LEGN's Carvykti Hit Blockbuster Status? ",3/21/2022 7:56:03 AM
INKT,MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results,3/18/2022 1:30:00 PM
INKT,MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update,3/3/2022 10:35:18 PM
INKT,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday,1/28/2022 12:32:32 PM
INKT,48 Biggest Movers From Yesterday,1/14/2022 10:43:03 AM
INKT,MiNK Therapeutics to Participate at Upcoming B. Riley Securities Virtual Oncology Conference,1/12/2022 3:41:30 PM
INKT,Agenus COO resigns to lead subsidiary MiNK Therapeutics,1/7/2022 12:09:53 PM
INKT,58 Biggest Movers From Yesterday,12/17/2021 10:43:57 AM
INKT,60 Biggest Movers From Yesterday,12/7/2021 11:14:30 AM
INKT,51 Biggest Movers From Yesterday,11/30/2021 10:45:59 AM
INKT,MiNK Therapeutics to Participate in 4th Annual Evercore ISI HealthCONx Conference,11/17/2021 10:15:00 PM
INKT,70 Biggest Movers From Friday,11/15/2021 10:40:07 AM
INKT,MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797,11/12/2021 1:00:00 PM
INKT,MiNK Therapeutics gains with bullish calls from analysts on cell therapy platform,11/9/2021 6:31:43 PM
INKT,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",11/8/2021 2:24:25 PM
INKT,66 Biggest Movers From Friday,11/1/2021 9:36:15 AM
INKT,Mid-Afternoon Market Update: Gold Down 1%; A10 Networks Shares Gain Following Q3 Results,10/29/2021 8:38:25 PM
INKT,MiNK Therapeutics Announces Closing of Initial Public Offering,10/19/2021 10:25:14 PM
